Dexamethasone implants appear to be the best treatment for persistent or recurrent macular edema that often occurs in patients with uveitis, findings from a new study show. The 12-week, multicenter, ...

Ophthalmologists in the US will soon have more options in their toolkit to manage neovascular age-related macular degeneration (AMD) and macular edema associated with uveitis. Susvimo, a 100 mg/mL ...

ANI Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for ILUVIEN, a fluocinolone acetonide intravitreal implant, allowing it to be used ...

Please provide your email address to receive an email when new articles are posted on . Complex, multifactorial and associated with at least 40 different disorders, uveitis is the fifth leading cause ...

Intravitreal ceftazidime may help treat syphilitic uveitis when IV penicillin is delayed. Ceftazidime is not a substitute for IV penicillin, which is the preferred treatment. A case series reported ...

Yutiq is supplied as a 0.18mg single-dose, preloaded applicator with a 25-gauge needle. EyePoint announced the launch of Yutiq (fluocinolone acetonide intravitreal implant) for the treatment of ...

The overarching mission of the Moran Eye Center’s Uveitis Division consists of three parts: to provide state-of-the-art, comprehensive, timely, and compassionate care to patients; to serve as leaders ...

Patients Treated in the Clinical Trial Exhibited Improvement in Best Corrected Visual Acuity No Meaningful Increases in IOP Observed; No Patient Required IOP-lowering Medication Clearside Biomedical, ...

Please provide your email address to receive an email when new articles are posted on . Young ophthalmologists looking to specialize in retina and uveitis management can tailor their career to be as ...

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced ...